Related Experiment Video
Updated: Aug 14, 2026

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
Published on: May 18, 2020
Genomic and proteomic analysis of mammary tumors arising in transgenic mice
Lu Xie1, Baogang J Xu, Agnieszka E Gorska
1Department of Cancer Biology, Biostatistics Shared Resource, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee 37232, USA.
Abstract:
Transforming growth factor-beta (TGF-beta) is the prototype of a large family of signaling molecules. TGF-beta signaling profoundly influences tumor development as demonstrated in several engineered mouse models. The present study was designed to identify differences by cDNA microarray and MALDI-TOF MS analyses in mammary carcinomas with and without TGF-beta signaling. The results demonstrate a significant potential for combination of profiling technologies to further understand the molecular mechanisms of breast cancer.
Insights
Transforming growth factor-beta (TGF-beta) signaling impacts tumor development. This study used gene profiling to find molecular differences in mammary tumors with and without TGF-beta signaling, advancing breast cancer research.
Area of Science:
- Molecular biology
- Cancer research
- Signal transduction
Background:
- Transforming growth factor-beta (TGF-beta) is a key signaling molecule with a significant role in tumor progression.
- Engineered mouse models demonstrate the profound influence of TGF-beta signaling on cancer development.
Purpose of the Study:
- To identify molecular differences in mammary carcinomas based on the presence or absence of TGF-beta signaling.
- To explore the utility of combined profiling technologies for understanding breast cancer.
Main Methods:
- cDNA microarray analysis to assess gene expression.
- MALDI-TOF MS (Matrix-Assisted Laser Desorption/Ionization–Time of Flight Mass Spectrometry) for protein analysis.
Main Results:
- Significant differences were observed in mammary carcinomas with and without TGF-beta signaling.
- The study highlights the potential of integrating gene and protein profiling.
Conclusions:
- Combining cDNA microarray and MALDI-TOF MS offers a powerful approach to elucidate molecular mechanisms in breast cancer.
- Understanding these molecular differences can contribute to improved diagnostics and therapeutics for breast cancer.
More Related Videos
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
07:52Orthotopic Injection of Breast Cancer Cells into the Mammary Fat Pad of Mice to Study Tumor Growth.
Published on: February 8, 2015